COMMUNIQUÉS West-GlobeNewswire
-
Fate Therapeutics Announces Presentations at 2026 ASCO and EULAR Annual Meetings Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases
21/05/2026 -
Iovance Biotherapeutics to Present at Upcoming Conference
21/05/2026 -
Akari Therapeutics Announces $5.5 Million Private Placement Offering
21/05/2026 -
Brain Cancer Canada Awards The Dwayne Andrews Glioblastoma Research Grant to Tackle One of the Most Aggressive Brain Tumours and Unlock Immunotherapy Breakthroughs for Young Patients
21/05/2026 -
NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation
21/05/2026 -
Tvardi Therapeutics to Participate in Upcoming Investor Events
21/05/2026 -
FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND
21/05/2026 -
Intuitive Announces Innovations to Advance Quintuple Aim
21/05/2026 -
Realize Medical Appoints Entrepreneur and Investor Tom Kaneb to Board of Directors
21/05/2026 -
Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
21/05/2026 -
SpyGlass Pharma to Participate in Upcoming Investor Conferences
21/05/2026 -
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency
21/05/2026 -
CytomX Therapeutics to Present at Upcoming June Investor Conferences
21/05/2026 -
Avalyn Announces Additional Long-term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to be Presented at the European Alliance of Associations for Rheumatology 2026
21/05/2026 -
SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH)
21/05/2026 -
‘For The Assist’: Haleon Canada launches national campaign with Canada Soccer to celebrate the small health supports behind Canadian wellbeing
21/05/2026 -
Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury
21/05/2026 -
NSK Dental Achieves Back-to-Back Top Ratings in Dental Product Shopper Peer Evaluations
21/05/2026 -
HCW Biologics Inc. Announces Pricing of Approximately $4.0 Million Private Placement Offering At-the-Market Under Nasdaq Rules
21/05/2026
Pages